This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
Melinta Therapeutics is a biopharmaceutical company with strong commercial and medical capabilities dedicated to providing innovative therapies to people impacted by acute and life-threatening illnesses. Melinta's current portfolio includes seven commercial stage products and one investigational product under review by FDA: BAXDELA (delafloxacin), KIMYRSA (oritavancin), MINOCIN (minocycline) for Injection, ORBACTIV (oritavancin), REZZAYO (rezafungin for injection), TOPROL-XL (metoprolol succinate), VABOMERE (meropenem and vaborbactam), and cefepime-taniborbactam. With an unsurpassed commitment to providers and patients, Melinta is dedicated to saving lives threatened by the global public health crisis of infections. We are small but mighty, with an unsurpassed commitment to patients, one another, and the business. We strive to offer a dynamic work environment, in which innovation, teamwork, knowledge and flexibility are valued. The purpose of this position is to provide support to Market Access Operations teams as needed. The Market Access Intern will take direction and work in close collaboration with the Market Access Leadership Team (MALT) to learn key concepts in market access, Hospital Systems, Infusion Services, Trade and Operations including analytics and planning, and content creation and approval processes.
